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ABSTRACT  1 
Background: The endothelium plays a key role in the maintenance of vascular health, and 2 
represents a potential physiological target for dietary and other lifestyle interventions designed 3 
to reduce risk for cardiovascular diseases (CVD) including stroke or coronary heart disease. 4 
Objective: To conduct a systematic review and meta-analysis of randomized controlled trials 5 
investigating effects of the Mediterranean dietary pattern (MedDiet) on endothelial function.  6 
Methods: Medline, Embase and Scopus databases were searched from inception until January 7 
2019 for studies that met the following criteria: 1) RCTs including adult participants, 2) 8 
interventions promoting a Mediterranean dietary pattern, 3) inclusion of a control group and 4) 9 
measurements of endothelial function.  A random-effects meta-analysis was conducted. Meta-10 
regression and sub-group analyses were performed to identify whether effects were modified 11 
by health status (i.e., healthy participants vs participants with existing comorbidities), type of 12 
intervention (i.e., MedDiet alone or with a co-intervention), study duration, study design (i.e., 13 
parallel or crossover), body mass index (BMI), and age of participants.   14 
Results: Fourteen articles reporting data for 1930 participants were included in the meta-15 
analysis. Study duration ranged from 4 weeks to 2.3 years. We observed a beneficial effect of 16 
the MedDiet on endothelial function (standardised mean difference (SMD): 0.35 95% CI: 0.17, 17 
0.53, P<0.001, I2 = 73.68%). MedDiet interventions improved flow mediated dilation (FMD) 18 
- the reference method for non-invasive, clinical measurement of endothelial function - by 19 
1.66% (absolute change; 95% CI: 1.15, 2.17, P<0.001, I2 = 0%). Effects of the MedDiet on 20 
endothelial function were not modified by health status, type of intervention, study duration, 21 
study design, BMI, and age of participants (P>0.05).   22 
Conclusions: MedDiet interventions improve endothelial function in adults, which suggest that 23 
the protective effects of the MedDiet are evident at early stages of the atherosclerotic process 24 





PROSPERO registration number: CRD42018106188.  26 
KEY WORDS: Mediterranean diet, endothelial function, flow mediated dilation, 27 
































INTRODUCTION  56 
The endothelium plays a key role in the maintenance of vascular health via the secretion of 57 
multiple signalling molecules including nitric oxide (NO), endothelins, selectins and adhesion 58 
molecules which, in concert, control vasomotor tone, and have anti-atherogenic and anti-59 
proliferative actions (1,2).  Loss of functional and structural integrity of the endothelium is 60 
thought to be an early pathogenic step in the development of atherosclerotic lesions and the 61 
subsequent onset of cardiovascular diseases (CVD) (3). Therefore, the endothelium has been 62 
identified as a tractable physiological target for therapeutic interventions designed to reduce 63 
risk for CVD such as stroke, coronary heart disease or peripheral arterial disease (4,5).   64 
 65 
The Mediterranean dietary pattern (MedDiet) is characterised by high consumption of olive 66 
oil, fruits, vegetables, legumes, nuts and seeds, and unrefined grains, moderate-to-high 67 
consumption of fish, and low consumption of red meat and sugar-sweetened products such as 68 
sweets, cakes, and pastries and is considered as one of the healthies dietary patterns (6,7).  69 
Evidence from randomised controlled trials (RCTs) such as the Lyon Diet Heart Study in 70 
France (8) and the Prevención con Dieta Mediterránea (PREDIMED) trial in Spain (9) 71 
demonstrates that the MedDiet is effective in both primary and secondary prevention of CVD.  72 
Improvements in endothelial function with the MedDiet may be one of the key mechanisms 73 
underpinning these beneficial effects (10).  Evidence from RCTs demonstrates that, in 74 
isolation, a number of components of the MedDiet, particularly olive oil (11), nuts (12), and 75 
oily fish (13,14), improve endothelial function.  In addition, there is evidence that the 76 
composite MedDiet enhances endothelial function in both healthy subjects and patients with 77 
cardiovascular and metabolic diseases.  For example, a 6 month MedDiet intervention in 78 
healthy older individuals induced highly significant improvements in endothelial function 79 





baseline values (absolute increase of ~1.3%) (15). Similarly, in patients with  pre-diabetes and 81 
diabetes a 1.5 year MedDiet intervention increased FMD by 1.1% and 1.4%, respectively (16).  82 
In addition, markers of endothelial structure such as carotid artery intima media thickness have 83 
also been shown to be improved with MedDiet interventions (17) 84 
 85 
A previous systematic review and meta-analysis in 2014 reported improved endothelial 86 
function and decreased inflammation with MedDiet versus control interventions (18).  87 
However, that review also included MedDiet-like interventions such as the Dietary Approach 88 
to Stop Hypertension (DASH) in the same analysis, which may elicit differential effects on 89 
endothelial function compared with the traditional MedDiet.  Moreover, in that systematic 90 
review, only studies with intervention period lasting ≥12 weeks were included, and the effects 91 
of shorter MedDiet interventions were not evaluated. These limitations, and the emergence of 92 
considerable new research in this area over the past 5 years (e.g. 14,15,17–19), provide the 93 
rationale for an updated systematic review and meta-analysis of RCTs.  Therefore, the aim of 94 
this study was to undertake a systematic review and meta-analysis of published RCTs exploring 95 
the effects of MedDiet interventions on structural (e.g., intima media thickness) and/or 96 
functional (e.g., FMD) measures of endothelial function in humans. In an attempt to understand 97 
potential differences in findings, we also investigated whether effects were modified by health 98 




The present systematic review was conducted according to the Preferred Reporting Items for 103 






Literature search 106 
Three databases (Medline, Embase and Scopus) were used to search for articles from inception 107 
until January 2019. In addition, a manual search of reference lists of relevant reviews and 108 
articles included in the systematic review was performed. The search was conducted based on 109 
the pre-defined search terms (Mediterranean AND diet*) AND (“endotheli*” [All Fields] OR 110 
“endothelial function” [All Fields] OR “endothelial dysfunction” [All Fields] OR “vascular 111 
function” [All Fields] OR “blood flow” [All Fields] OR “vascular reactivity” [All Fields] OR 112 
“vasodilation” [All Fields]) and (Mediterranean AND diet*) AND (“Flow-mediated dilatation” 113 
OR “Flow-mediated dilation” OR FMD OR “Venous occlusion plethysmography” OR 114 
“Peripheral arterial tonometry” OR “Nitric oxide” OR “Endothelial function” OR “Endothelial 115 
dysfunction” OR “Carotid Intima-Media Thickness” OR “Pulse Wave Velocity” OR  116 
“Augmentation Index”).  Further details of the search strategy are provided in Supplemental 117 
Methods 1.   118 
 119 
Study selection 120 
The following criteria were applied to identify articles to be included in this systematic review 121 
and meta-analysis: 1) RCTs (no further exclusion criteria were applied in relation to study 122 
design or blinding); 2) studies involving adults aged ≥18 years and no exclusion criteria were 123 
applied for health status or smoking history; 3) MedDiet (which was defined as a MedDiet by 124 
the authors of each study) administered alone or with other clinical, pharmaceutical or lifestyle 125 
interventions if a comparable and valid control group was included (for example, MedDiet plus 126 
exercise compared to control group including exercise alone); 4) studies reporting changes in 127 
endothelial function for intervention and control groups separately; 5) no language or time 128 






Two investigators (CH, IM) independently screened the titles and abstracts of the articles to 131 
evaluate eligibility for inclusion. If consensus was reached, articles were either excluded or 132 
moved to the next stage (full-text). If consensus was not reached the articles was moved to the 133 
full-text stage. The full-texts of the selected articles were appraised critically to determine 134 
eligibility for inclusion in the systematic review. Disagreements were resolved by discussion 135 
between the reviewers (including MS) until consensus was reached. 136 
 137 
Data extraction and quality assessment 138 
Data extraction was completed by one investigator (CH) and data entries were checked for 139 
accuracy by a second investigator (IM). The following information was extracted from the 140 
eligible articles: author, year of publication, country, study design, inclusion and exclusion 141 
criteria, study duration, run-in phase, intention to treat analysis, sample size, type of 142 
intervention (control and MedDiet), age, sex, ethnicity, randomisation procedure, blinding of 143 
exposure and outcome measurements, compliance with the interventions, BMI, dietary 144 
intervention, weight loss during the study, baseline and post-intervention measurements of 145 
systolic and diastolic blood pressure (BP), baseline and post-intervention measurements of 146 
endothelial function. In addition, two independent reviewers (CH, IM) utilised the Cochrane 147 
risk of bias tool to assess the risk of bias of the included studies which was classified as 1) high 148 
risk, 2) low risk or 3) unknown risk of bias (22) and any discrepancy was resolved by consensus 149 
with a third reviewer (MS) 150 
 151 
Statistical analysis 152 
Statistical analyses were performed by using Comprehensive Meta-Analysis Software Version 153 
2 (Biostat, Englewood, NJ, USA). For this purpose, sample size, the mean and SD of the 154 





intervention and control) were extracted and used in the analyses. When no baseline 156 
measurements were reported, the sample size, means and SDs after the intervention were used. 157 
If the mean and SD were not given, the sample size and the P value of the difference between 158 
MedDiet and control were used to calculate the effect size (Cohen’s d). For studies that reported 159 
changes in endothelial function at two or more time-points, the last endothelial function 160 
measurement was used in the meta-analysis. The calculation of the effect sizes using different 161 
sets of data is performed automatically by the software using integrated algorithms (23). Data 162 
not provided in the main text or tables were extracted from the figures. Some trials used more 163 
than one method to assess changes in endothelial function (Table 1) which may lead to a 164 
reduced independence of the measurements and, consequently, to over-estimation of the effect 165 
size derived from the meta-analysis. This potential confounding factor was taken into account 166 
during analysis by estimating the mean of the standardised effect sizes derived from each 167 
endothelial function measurement within each such study to provide a more conservative 168 
estimate of the effect size. 169 
 170 
Effect sizes and 95% confidence intervals for the MedDiet interventions were calculated using 171 
a using a weighted DerSimonian-Laird random effects model (24). Forest plots were generated 172 
to present graphically the cumulative effect of MedDiet on endothelial function. Analyses were 173 
conducted on all endothelial function measurements but also stratified by type of endothelial 174 
function measurement (structural and functional). Functional measurements include FMD 175 
derived from ultrasound, forearm blood flow (FBF) derived from phlethysmography or 176 
cutaneous microcirculation derived from laser Doppler. Structural measurements include 177 
intima media thickness or vessel size measured both by ultrasound. In addition, we performed 178 





reference method for non-invasive, clinical measurement of endothelial function (25) and was 180 
used in the majority of studies.   181 
 182 
Subgroup analyses were undertaken to investigate variables which may have influenced the 183 
effects of MedDiet on endothelial function. These factors included: health status (healthy 184 
subjects vs patients with existing comorbidities), type of intervention (MedDiet alone or 185 
administered with other clinical or pharmaceutical interventions), type of endothelial function 186 
measurement (functional versus structural) and study design (parallel or crossover). Random-187 
effect meta-regression analyses were used to determine whether participant baseline 188 
characteristics (age, BMI) and duration of the study influenced the effect of the MedDiet on 189 
endothelial function. Funnel plots and Egger’s regression tests were performed to evaluate the 190 
risk of publication bias. Heterogeneity was assessed by using Cochrane Q statistic; P<0.1 191 
indicates significant heterogeneity. The I2 test was also utilised to assess heterogeneity across 192 
trials where a value < 25% indicates low risk, 25-75% indicates moderate risk, and >75% 193 
indicates a high risk (26). Sensitivity analyses were conducted to identify the source of 194 
heterogeneity by conducting stratified analyses or selectively removing studies with larger 195 
effect size. All of the data used in the meta-analysis can be found in Supplemental Tables 1-196 
5.   197 
 198 
RESULTS 199 
Search results 200 
The process of screening and selection of the studies is summarised in Figure 1. The primary 201 
search of the three databases produced 12857 articles, after removal of duplicates. After title 202 
and abstract screening, 15 full-text papers were retrieved for further evaluation. A further four 203 





Examination of the full text of the 19 included articles yielded 14 studies which were eligible 205 
to be included in this systematic review and meta-analysis. Some of these papers reported 206 
results from independent studies testing the effects of MedDiet on endothelial function 207 
generating a total of 20 sets of independent measures of endothelial function using different 208 
methods that were included in the meta-analyses.   209 
 210 
Study characteristics 211 
The total number of participants from the 14 articles included in this systematic review was 212 
1930 with a median of 131 (range 20 - 438) participants per study. The median participant age 213 
was 55 (range 38 - 71) years. Eleven of the RCTs included in the meta-analysis were parallel 214 
trials with a control group, while 3 were crossover studies (22). The paired nature of the cross-215 
over trials was taken into account in the meta-analysis to minimise unit-of-analysis errors and 216 
underestimation of the effect size. The duration of the interventions ranged from 4 weeks to 217 
121 weeks (Table 1). Five studies investigated the effect of MedDiet in healthy participants 218 
(15,16,27–29), three in people with diabetes (16,17,19), two in patients with elevated risk of 219 
CVD (30,31), two in overweight or obese participants (20,32), one in patients with metabolic-220 
syndrome (33), one in people with pre-diabetes (16), one in patients with acute coronary 221 
syndrome (34), and one in hypercholesteraemic men (35). Various permutations of the 222 
MedDiet were prescribed, including: a MedDiet (n=8), a MedDiet plus supplementary nuts 223 
(n=2), a MedDiet plus supplementary extra virgin olive oil (n=5), a MedDiet plus mono-224 
unsaturated fatty acids (n=2), and a MedDiet plus exercise (n=1).  Additionally, a variety of 225 
different control groups were employed.  These were: a low-fat diet (n=8), a typical Swedish 226 
diet (n=1), the Atkins low-carbohydrate diet (n=1), the participants habitual diet (n=2), the 227 
National Cholesterol Education Program Diet (n=1), a non-Mediterranean diet plus exercise 228 





to assess endothelial function in the included trials. The most commonly used methods were 230 
FMD and carotid intima-media thickness. Other methods included forearm blood flow, 231 
cutaneous microvascular function, baseline vessel size, and calculation of an endothelial 232 
function score (Table 1).  233 
 234 
Meta-analysis 235 
Meta-analysis of the 20 sets of independent results showed that, overall, MedDiet improved 236 
endothelial function (SMD: 0.35, 95% CI: 0.17, 0.53, P<0.001; Figure 2). Heterogeneity 237 
between studies was significant (Q=64.60, I2=73.68%, P<0.001). However, the removal of two 238 
studies with wider effect estimates (27,33) (Supplemental Fig. 1) explained the heterogeneity 239 
of the results (Q=13.82, I2=0%, P=0.53) while still confirming a significant effect of MedDiet 240 
on endothelial function (SMD: 0.27, 95% CI: 0.18, 0.36, P<0.001). The subgroup analyses 241 
showed that the effect was stronger on functional (SMD: 0.44, 95% CI: 0.19, 0.69, P<0.001; 242 
I2=78.2%) compared with structural (SMD: 0.16, 95% CI: 0.02, 0.30, P=0.01; I2=0%) 243 
measurements of endothelial function. MedDiet increased FMD by 1.66% (95% CI: 1.15, 2.17, 244 
P<0.001; Figure 3). Subgroup analyses showed that MedDiet improved endothelial function 245 
significantly in healthy participants (SMD: 0.29, 95% CI: 0.05, 0.53, P=0.01; I2=26.5%) and 246 
in those with increased risk of CVD (SMD: 0.36, 95% CI: 0.15, 0.58, P=0.001; I2=79.1%). The 247 
effects of the MedDiet on endothelial function were not modified significantly by the type of 248 
study design (crossover or parallel) or type of intervention (MedDiet alone or combined; Table 249 
2). Meta-regression analyses demonstrated no modification of the effect size by age, BMI or 250 
study duration (Table 3). However, a significant association was found between study duration 251 
(in weeks) with functional (slope: 0.006; SE: 0.003; P=0.04; Figure 4A) but not structural 252 






Study quality and publication bias 255 
Overall, the quality of the trials was modest as the majority of the studies failed to report key 256 
information to assess the presence of bias. Attrition bias was present in 50% of the studies (15–257 
17,20,31,33,34) and few studies reported selection bias (<10% of the studies) (20).  Seven 258 
studies described the randomisation method (15–17,19,28,33,34), and three studies stated the 259 
methods of allocation concealment (17,29,33).  Five studies reported and described participant 260 
dropout (19,27–29,32), while three studies described selective reporting of the results 261 
(20,29,34) (Supplemental Fig. 2). Visual inspection of the Funnel plot revealed two studies 262 
with wider effect estimates but overall there was no evidence of publication bias, which was 263 
confirmed by Egger’s Regression test (P=0.71; Supplemental Fig. 1).  264 
 265 
DISCUSSION 266 
Overall, the results of this meta-analysis demonstrate that a MedDiet improves endothelial 267 
function. The beneficial effects are evident for both functional and structural measures of 268 
endothelial function, although effects were stronger for functional measures.  In addition, the 269 
effects of a MedDiet were similar in both healthy participants and those at increased risk of 270 
CVD and, overall, were not modified by the study design or duration, type of intervention, BMI 271 
or age of participants.   272 
 273 
In a previous systematic review and meta-analysis, Schwingshackl and Hoffmann (18) reported 274 
improvements in endothelial function with MedDiet interventions. In particular, MedDiet 275 
interventions increased FMD by 1.86%, which is similar to the 1.66% average improvement in 276 
FMD observed in this analysis.  Importantly, the pooled effect size reported by Schwingshackl 277 
and Hoffmann (18) was based on the results of only two studies, where as our meta-analysis 278 





confidence to this result.  To contextualise these findings, a meta-analysis by Inaba et al (36) 280 
demonstrated a 13% decrease in the risk of cardiovascular events per 1% increase in FMD.  281 
Thus, a 1.66% improvement in FMD with a MedDiet could potentially translate into a ~22% 282 
reduction in cardiovascular events; however, these results require a cautious interpretation and 283 
need corroboration in future, more robust studies.  As the MedDiet may also reduce CVD risk 284 
via a range of other mechanisms, some of which may be independent of effects on endothelial 285 
function (e.g. reduced BP, decreased oxidative stress and inflammation, altered gut microbiome 286 
(37)), the overall effects of this dietary pattern on CVD risk may be even greater.  Indeed, in 287 
the large-scale PREDIMED trial, CVD incidence was reduced by 31% and 28% with an 288 
average 4.8 year MedDiet intervention supplemented with additional olive oil or nuts, 289 
respectively (9).  A novel finding of the present analysis was that MedDiet interventions also 290 
improved structural measures of endothelial function (e.g. carotid intima-media thickness).  291 
However, effects were less pronounced than for functional changes and meta-regression 292 
revealed no relationship between study duration and effects of the MedDiet on structural 293 
outcomes.  By contrast, there was a positive association between study duration and 294 
improvement in functional measures of endothelial function.  This suggests that longer term 295 
consumption of the MedDiet may maximise the effects of this dietary pattern on functional 296 
measures of endothelial function, whilst structural changes appear to be relatively modest 297 
irrespective of the duration of exposure to this dietary pattern.   298 
 299 
There are several mechanisms through which the MedDiet could improve endothelial function, 300 
which may account for the beneficial effects observed in this study. Firstly, the MedDiet 301 
augments the bioavailability of nitric oxide (NO) (38), which is essential for healthy endothelial 302 
function due to its vasodilatory, anti-atherogenic and anti-proliferative actions (5).   The NO 303 





scavenging of NO (38,39), the provision of  the NO precursors inorganic nitrate (green leafy 305 
vegetables) and L-arginine (nuts, grains, legumes, and fish) (39), and/ or the upregulation of 306 
endothelial NO synthase (oily fish) (40,41).  In addition, the MedDiet may improve endothelial 307 
function by reducing oxidation of low-density lipoprotein (LDL) (42), which plays a major role 308 
in endothelial dysfunction and atherogenesis (43,44).  The lower levels of oxidised LDL with 309 
the MedDiet are likely mediated by both the antioxidant effects of this dietary pattern and the 310 
increased provision of monounsaturated fatty acids which enhance the resilience of LDL to 311 
oxidation (45).  Finally, a strong link has been reported between inflammation and endothelial 312 
dysfunction (46), and several studies have demonstrated beneficial effects of the MedDiet on 313 
inflammatory markers including interleukin-6 (IL-6), c-reactive protein (CRP), tumour 314 
necrosis factor-α (TNF-α), vascular cell adhesion protein-1 (VCAM-1), and soluble 315 
intercellular adhesion molecule-1 (sICAM-1) (47–50). These effects are associated with 316 
downregulation of the NF-kB pathway (51) and altered methylation of inflammation-related 317 
genes (50), and may further contribute towards improvements in endothelial function with a 318 




The overall quality of the studies included was modest.  The majority of investigations did not 323 
blind participants to the intervention arm, with only three studies reporting methods of 324 
allocation concealment.  This is a notable limitation, given the risk of expectation bias whereby 325 
the expectation of beneficial effects could result in more favourable outcomes in the 326 
intervention group (52).  Nevertheless, it is acknowledged that blinding participants is very 327 
difficult in dietary intervention studies, particularly those advocating dietary pattern changes, 328 





endothelial function over the duration of the trial and, for studies with longer duration, this may 330 
result in a decline of the effects on endothelial function due to a gradual decrease of the 331 
adherence to the interventions. However, we included the last measurement in the meta-332 
analysis to standardize the approach across studies and remove any bias related to the selection 333 
of the intermediate measurements to be included in the analysis. A further limitation is that 334 
most studies were conducted in older subjects.  Although meta-regression revealed no influence 335 
of age on the effects of the MedDiet, the lack of younger participants may limit our ability to 336 
generalise our conclusions, and further research is warranted to determine if the results are 337 
applicable to individuals at different life stages.  Additionally, since there is no universal 338 
definition of what constitutes a MedDiet, details of the dietary interventions differed between 339 
studies, and it is possible that certain permutations of the MedDiet may be more effective than 340 
others in improving endothelial function as was evident from the high heterogeneity in our 341 
analysis. Likewise, the control group utilised was highly variable, such that there was no 342 
uniform benchmark against which the MedDiet was compared, which may further contribute 343 
towards the high heterogeneity in our analysis.  Finally, there are also certain methodological 344 
limitations of this review which warrant discussion.  Notably, we decided to only include 345 
studies where the authors identified their intervention as a MedDiet.  This means that we may 346 
have missed some studies which administered a Mediterranean-type diet but which was not 347 
defined using this specific terminology.  In addition, given the small number of studies included 348 
in this review, our analysis may have been underpowered to detect differences in intervention 349 
effectiveness based on health status, type of intervention, type of measurement, and study 350 









The present systematic review and meta-analysis demonstrates that the MedDiet improves both 356 
functional and structural measures of endothelial function, which likely make a large 357 
contribution towards the consistently observed beneficial effects of this dietary pattern on 358 
cardiovascular health. However, the overall quality of the evidence was modest and more 359 
robust and well-designed trials are need to corroborate the evidence highlighting positive 360 
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Table 1: Summary of main characteristics of randomized clinical trials investigating the effects of Mediterranean Diet on endothelial function in adults 
ACS, Acute Coronary Syndromes; BVS, Baseline Vessel Size; CIMT, Carotid Intima-Media Thickness; CM, Cutaneous Microvascular Function; CVD risk, Risk of Cardiovascular Disease; DBP, Diastolic Blood Pressure; DM2, Type 2 
Diabetes; EFS, Endothelial Function Score; EVOO, Extra Virgin Olive Oil; FBF, Forearm Blood Flow; FMD, Flow Mediated Dilatation; ICA-IMT, Internal Carotid Intima-Media Thickness; MedDiet, Mediterranean Diet; MetS, Metabolic 
Syndrome; MUFA, Monounsaturated Fatty Acids; n = number of subjects; NCEP-1, The National Cholesterol Education Program Diet; pDM2, prediabetes; SBP, Systolic Blood Pressure.  
 










Type of Intervention Type of Control 
Ambring et al. (27) Sweden Cross-over Healthy FBF 22 12 43 26.0 NR 12 MedDiet Swedish Diet 
Buscemi et al. (32) Italy Parallel Obese FMD 20 0 38 34.2 128/88 8 MedDiet Atkins Low-carbohydrate 
Ceriello et al. (19) Spain Parallel DM2 FMD 24 17 NR 29.5 116/78 12 MedDiet  + MUFA Low Fat Diet 
Davis et al. (15) Australia Parallel Healthy FMD 166 72 71 26.9 124/71 24 MedDiet Habitual Diet 
Esposito et al. (33) Italy Parallel MetS EFS 180 89 44 28.0 135/86 96 MedDiet Prudent Diet 
Fuentes et al. (35) Spain Cross-over Hypercholesteremic FMD, BVS 22 22 40 NR NR 8 MedDiet  + MUFA NCEP-1 Diet 
Jaacks et al. (20) USA Parallel Overweight FMD 30 8 51 31.5 NR 8 MedDiet Habitual Diet 
Klonizakis et al. (28) UK Parallel Healthy CM 22 7 55 30.5 127/79 8 MedDiet  + Exercise Non-MedDiet + Exercise 
Maiorino et al. (17) Italy Parallel DM2 CIMT 215 106 52 29.6 140/87 121 MedDiet Low Fat Diet 
Marin et al. (29) Spain Cross-over Healthy CM 20 10 67 31.9 NR 4 MedDiet Saturated Fatty Acid Diet 
Murie-Fernandez et al. (30) Spain Parallel CVD risk CIMT 187 91 67 29.4 NR 48 G1:  MedDiet + EVOO 
G2:  MedDiet + Nuts 
Low Fat Diet 
Sala-Vila et al. (31) Spain Parallel CVD risk ICA-IMT 175 42 66 29.6 150/81 115 G1:  MedDiet + EVOO 
G2:  MedDiet + Nuts 
Low Fat Diet 
Thomazella et al. (34) Brazil Parallel ACS FMD, BVS 42 42 55 26.4 136/84 12 MedDiet Low Fat Diet 
Torres-Peña et al. (16) Spain Parallel DM2 FMD 438 NR 61 31.8 NR 72 MedDiet + EVOO Low Fat Diet 
Torres-Peña et al. (16) Spain Parallel pDM2 FMD 289 NR 58 30.3 NR 72 MedDiet + EVOO Low Fat Diet 





Table 2: Sensitivity analysis to evaluate the influence of health status, type of intervention, 
type of measurement, and study design on the effects of the Mediterranean dietary pattern on 
endothelial function (EF) in adults. 
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CVD risk = Risk of Cardiovascular Disease. MedDiet = Mediterranean dietary pattern. P 
refers to the effect sizes of the subgroups in each category. P between Groups refers to the 






Table 3: Meta-regression analysis to evaluate potential modifiers of the effects of 
Mediterranean dietary pattern on endothelial function in adults.    
 Slope SE Q (df=1) P  
Age (years) -0.002 0.008 0.12 0.72 
Study Duration (weeks) 0.0008 0.002 0.17 0.67 








Figure 1: Flow diagram of the selection process of the randomized controlled trials included 








Figure 2: Forest plot showing the overall effect of the Mediterranean dietary pattern on 
endothelial function in adults. DM2 = type 2 diabetes; pDM2 = pre-diabetes; a = MedDiet + 
extra virgin olive oil; b = MedDiet + nuts.  Data showed as standardised differences in means. 
Horizontal lines denote 95% confidence intervals (CI). The size of the boxes is proportionally 








Figure 3: Forest plot showing the overall effect of the Mediterranean dietary pattern on flow 
mediated dilation in adults (expressed as percent change). DM2 = type 2 diabetes; pDM2 = 
pre-diabetes. Data showed as percent differences in means. Horizontal lines denote 95% 
confidence intervals (CI). The size of the boxes is proportionally scaled to the effect size for 







Figure 4:  Meta-regression analysis of the association between study duration and the effect 
size (expressed as standardised mean difference [SMD]) of functional (A) and structural (B) 
alterations in endothelial function in adult subjects following consumption of a Mediterranean 
dietary pattern.  
 
